Ad is loading...
LGMNX
Price
$26.74
Change
-$0.28 (-1.04%)
Updated
Nov 15 closing price
RCEEX
Price
$71.49
Change
-$0.32 (-0.45%)
Updated
Nov 15 closing price
Ad is loading...

LGMNX vs RCEEX

Header iconLGMNX vs RCEEX Comparison
Open Charts LGMNX vs RCEEXBanner chart's image
Loomis Sayles Global Allocation N
Price$26.74
Change-$0.28 (-1.04%)
VolumeN/A
CapitalizationN/A
American Funds Capital Income Bldr R2E
Price$71.49
Change-$0.32 (-0.45%)
VolumeN/A
CapitalizationN/A
LGMNX vs RCEEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGMNX vs. RCEEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGMNX is a StrongBuy and RCEEX is a Buy.

FUNDAMENTALS
Fundamentals
RCEEX has more cash in the bank: 107B vs. LGMNX (3.03B). RCEEX pays higher dividends than LGMNX: RCEEX (2.85) vs LGMNX (0.43). LGMNX was incepted earlier than RCEEX: LGMNX (8 years) vs RCEEX (10 years). RCEEX is a more actively managed with annual turnover of: 106.00 vs. LGMNX (19.00). RCEEX has a lower initial minimum investment than LGMNX: RCEEX (250) vs LGMNX (1000000). LGMNX (18.18) and RCEEX (17.34) have marching annual gain over last year. RCEEX return over 5 years is better than : 25.26 vs. LGMNX (10.79).
LGMNXRCEEXLGMNX / RCEEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years10 years-
Gain YTD13.93310.184137%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.03B107B3%
Annual Yield % from dividends0.432.8515%
Returns for 1 year18.1817.34105%
Returns for 3 years-13.5510.58-128%
Returns for 5 years10.7925.2643%
Returns for 10 yearsN/A32.43-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TXNM46.300.49
+1.07%
TXNM Energy Inc
SBSI35.890.21
+0.59%
Southside Bancshares Inc
EML27.50-0.65
-2.31%
Eastern Company
CELH25.66-1.27
-4.72%
Celsius Holdings
CARA0.31-0.02
-5.04%
Cara Therapeutics